| scholarly article | Q13442814 |
| P2093 | author name string | S L Kunkel | |
| M Amat | |||
| J Beleta | |||
| N Prats | |||
| L M Williams | |||
| N Godessart | |||
| C F Benjamim | |||
| E Terricabras | |||
| P2860 | cites work | Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes | Q22253300 |
| International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 | ||
| Macrophage inflammatory protein-1 | Q28211059 | ||
| Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1 | Q28375207 | ||
| Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
| A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. | Q31395542 | ||
| Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis | Q33902443 | ||
| Amelioration of rat adjuvant-induced arthritis by Met-RANTES. | Q34130186 | ||
| Chemokines in autoimmune disease | Q34418051 | ||
| New therapeutics that modulate chemokine networks | Q34743328 | ||
| Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice | Q35049062 | ||
| Development and evaluation of pharmacological agents targeting chemokine receptors | Q35119358 | ||
| C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
| Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
| The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis | Q35762757 | ||
| CCR1 antagonists for the treatment of autoimmune diseases | Q35808573 | ||
| Drug discovery and chemokine receptor antagonists: eppur si muove! | Q35952059 | ||
| Chemokines and their receptors in rheumatoid arthritis: future targets? | Q36063483 | ||
| Chemokine receptors: attractive targets for drug discovery | Q36242888 | ||
| Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis | Q37253521 | ||
| Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection | Q37303301 | ||
| Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia | Q38919861 | ||
| A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation | Q39737420 | ||
| Design, synthesis, and discovery of a novel CCR1 antagonist | Q40811774 | ||
| A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection | Q40845773 | ||
| Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors | Q40920168 | ||
| CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases | Q42605598 | ||
| Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. | Q43511392 | ||
| Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis | Q43607170 | ||
| Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice | Q44903326 | ||
| CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome | Q45166206 | ||
| Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis | Q46102304 | ||
| Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor | Q47882990 | ||
| Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines | Q48045988 | ||
| Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice | Q57019206 | ||
| Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis | Q58443833 | ||
| Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis | Q62820063 | ||
| Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes | Q71802304 | ||
| The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy | Q73045776 | ||
| Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice | Q73458501 | ||
| The inhibitory effect of rolipram on TNF-alpha production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline | Q73561405 | ||
| Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease | Q74027234 | ||
| Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent | Q74165253 | ||
| Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram | Q74460278 | ||
| Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression | Q77872967 | ||
| Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation | Q78551261 | ||
| An essential role for CCL3 in the development of collagen antibody-induced arthritis | Q81723079 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 666-675 | |
| P577 | publication date | 2006-10-03 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo | |
| P478 | volume | 149 |
| Q34389532 | A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation |
| Q37707714 | Activation of the cholinergic anti-inflammatory system by nicotine attenuates arthritis via suppression of macrophage migration |
| Q35715328 | Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1. |
| Q35234755 | CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells |
| Q33677606 | CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis |
| Q26824580 | Cellular targeting in autoimmunity |
| Q34262218 | Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara |
| Q37349685 | Chemokine receptor antagonists: overcoming developmental hurdles |
| Q35021422 | Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium |
| Q34051768 | Chemokines and chemokine receptors in arthritis |
| Q91199065 | Chemokines in rheumatic diseases: pathogenic role and therapeutic implications |
| Q34365089 | Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model |
| Q38188862 | Emerging immunotherapies for rheumatoid arthritis. |
| Q54227941 | Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy. |
| Q40215297 | Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice |
| Q41849684 | Macrophages and angiogenesis in rheumatic diseases |
| Q92086083 | OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy |
| Q48193375 | Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5. |
| Q42242681 | Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats |
| Q57787493 | Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2 |
| Q37570595 | Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis |
| Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
| Q38647749 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis |
| Q36057569 | The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours |
| Q92496416 | The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behçet's disease mouse model |
| Q34076041 | Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation |
Search more.